{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T09:46:50Z","timestamp":1794217610501,"version":"4.8.0"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T00:00:00Z","timestamp":1707177600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.biopha.2024.116259","type":"journal-article","created":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T20:50:05Z","timestamp":1707943805000},"page":"116259","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Subtle structural alteration in indisulam switches the molecular mechanisms for the inhibitory effect on the migration of gastric cancer cells"],"prefix":"10.1016","volume":"172","author":[{"given":"Changxu","family":"Hou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaomei","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoqi","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgane","family":"El\u00e9ou\u00ebt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunhua","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4753-4769","authenticated-orcid":false,"given":"Guoqiang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2024.116259_bib1","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0140-6736(20)31288-5","article-title":"Gastric cancer","volume":"396","author":"Smyth","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.biopha.2024.116259_bib2","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.3390\/ijms21114012","article-title":"Gastric cancer: Epidemiology, risk factors, classification, genomic characteristics and treatment strategies","volume":"21","author":"Machlowska","year":"2020","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.biopha.2024.116259_bib3","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.cgh.2019.07.045","article-title":"Burden of gastric cancer","volume":"18","author":"Thrift","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.biopha.2024.116259_bib4","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11912-019-0820-4","article-title":"Updates on management of gastric cancer","volume":"21","author":"Johnston","year":"2019","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.biopha.2024.116259_bib5","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1038\/nm.3391","article-title":"Tumor metastasis: Moving new biological insights into the clinic","volume":"19","author":"Wan","year":"2013","journal-title":"Nat. Med"},{"key":"10.1016\/j.biopha.2024.116259_bib6","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/s41580-018-0080-4","article-title":"New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer","volume":"20","author":"Dongre","year":"2019","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.biopha.2024.116259_bib7","doi-asserted-by":"crossref","first-page":"965","DOI":"10.3390\/molecules21070965","article-title":"Targeting epithelial-mesenchymal transition (EMT) to overcome drug resistance in cancer","volume":"21","author":"Du","year":"2016","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2024.116259_bib8","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrclinonc.2017.44","article-title":"EMT, CSCs, and drug resistance: The mechanistic link and clinical implications","volume":"14","author":"Shibue","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.biopha.2024.116259_bib9","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1146\/annurev.pa.16.040176.001521","article-title":"Relatons between structure and biological activity of sulfonamides","volume":"16","author":"Maren","year":"1976","journal-title":"Annu Rev. Pharm. Toxicol."},{"key":"10.1016\/j.biopha.2024.116259_bib10","first-page":"316","article-title":"A novel agent ER-35744, targeting G1 phase II: Antitumor activities in vitro and in vivo","volume":"37","author":"Sugi","year":"1996","journal-title":"Proc. Am. Assoc. Cancer Res"},{"key":"10.1016\/j.biopha.2024.116259_bib11","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.bmcl.2003.09.062","article-title":"Carbonic anhydrase inhibitors: E7070, a sulfonamide anticancer agent, potently inhibits cytosolic isozymes I and II, and transmembrane, tumor-associated isozyme IX","volume":"14","author":"Abbate","year":"2004","journal-title":"Bioorg. Med Chem. Lett."},{"key":"10.1016\/j.biopha.2024.116259_bib12","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1080\/13543784.2018.1548608","article-title":"Carbonic anhydrase inhibitors as emerging agents for the treatment and imaging of hypoxic tumors","volume":"27","author":"Supuran","year":"2018","journal-title":"Expert Opin. Invest. Drugs"},{"key":"10.1016\/j.biopha.2024.116259_bib13","first-page":"275","article-title":"Profiling novel sulfonamide antitumor agents with cell-based phenotypic screens and array-based gene expression analysis","volume":"1","author":"Yokoi","year":"2002","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.biopha.2024.116259_bib14","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1016\/S0959-8049(01)00275-1","article-title":"E7070, a novel sulphonamide agent with potent antitumour activity in vitro and in vivo","volume":"37","author":"Ozawa","year":"2001","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.biopha.2024.116259_bib15","doi-asserted-by":"crossref","DOI":"10.1126\/science.aal3755","article-title":"Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15","volume":"356","author":"Han","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.biopha.2024.116259_bib16","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/nchembio.2363","article-title":"Selective degradation of splicing factor CAPER\u03b1 by anticancer sulfonamides","volume":"13","author":"Uehara","year":"2017","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.biopha.2024.116259_bib17","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/j.str.2019.10.005","article-title":"Structural basis and kinetic pathway of RBM39 recruitment to DCAF15 by a sulfonamide molecular glue E7820","volume":"27","author":"Du","year":"2019","journal-title":"Structure"},{"key":"10.1016\/j.biopha.2024.116259_bib18","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41589-019-0378-3","article-title":"Structural complementarity facilitates E7820-mediated degradation of RBM39 by DCAF15","volume":"16","author":"Faust","year":"2020","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.biopha.2024.116259_bib19","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1136\/gutjnl-2011-301153","article-title":"TPX2 and AURKA promote 20q amplicon-driven colorectal adenoma to carcinoma progression","volume":"61","author":"Sillars-Hardebol","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.biopha.2024.116259_bib20","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.4161\/cc.28156","article-title":"CAPER, a novel regulator of human breast cancer progression","volume":"13","author":"Mercier","year":"2014","journal-title":"Cell Cycle"},{"key":"10.1016\/j.biopha.2024.116259_bib21","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ccell.2019.01.010","article-title":"Targeting an RNA-binding protein network in acute myeloid leukemia","volume":"35","author":"Wang","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.biopha.2024.116259_bib22","doi-asserted-by":"crossref","first-page":"4462","DOI":"10.1021\/acs.jproteome.1c00437","article-title":"Proximity labeling, quantitative proteomics, and biochemical studies revealed the molecular mechanism for the inhibitory effect of indisulam on the proliferation of gastric cancer cells","volume":"20","author":"Lu","year":"2021","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.biopha.2024.116259_bib23","article-title":"Insights on the biological functions and diverse regulation of RNA-binding protein 39 and their implication in human diseases","volume":"2023","author":"Eleouet","year":"1866","journal-title":"Biochim. Biophys. Acta Gene Regul. Mech."},{"key":"10.1016\/j.biopha.2024.116259_bib24","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1097\/00001813-200211000-00002","article-title":"E7070: A novel synthetic sulfonamide targeting the cell cycle progression for the treatment of cancer","volume":"13","author":"Van Kesteren","year":"2002","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.biopha.2024.116259_bib25","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/annonc\/mdi016","article-title":"E.N.D. Development, G. Melanoma, Phase II study of E7070 in patients with metastatic melanoma","volume":"16","author":"Smyth","year":"2005","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.biopha.2024.116259_bib26","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1158\/1078-0432.CCR-06-0249","article-title":"A randomized phase II pharmacokinetic and pharmacodynamic study of indisulam as second-line therapy in patients with advanced non-small cell lung cancer","volume":"13","author":"Talbot","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2024.116259_bib27","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1002\/cncr.31398","article-title":"Final results of a phase 2, open-label study of indisulam, idarubicin, and cytarabine in patients with relapsed or refractory acute myeloid leukemia and high-risk myelodysplastic syndrome","volume":"124","author":"Assi","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.biopha.2024.116259_bib28","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1021\/jm0306430","article-title":"Glide: A new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy","volume":"47","author":"Friesner","year":"2004","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.biopha.2024.116259_bib29","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1002\/jcc.20290","article-title":"K.M. Merz, Jr., A. Onufriev, C. Simmerling, B. Wang, R.J. Woods, The Amber biomolecular simulation programs","volume":"26","author":"Case","year":"2005","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.biopha.2024.116259_bib30","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1001\/jamasurg.2022.0182","article-title":"Surgical management of gastric cancer: a review","volume":"157","author":"Li","year":"2022","journal-title":"JAMA Surg."},{"key":"10.1016\/j.biopha.2024.116259_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2023.103025","article-title":"The aryl sulfonamide indisulam inhibits gastric cancer cell migration by promoting the ubiquitination and degradation of the transcription factor ZEB1","volume":"299","author":"Lu","year":"2023","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.biopha.2024.116259_bib32","doi-asserted-by":"crossref","first-page":"7624","DOI":"10.3390\/ijms21207624","article-title":"Role of cadherins in cancer-a review","volume":"21","author":"Kaszak","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2024.116259_bib33","doi-asserted-by":"crossref","first-page":"3429","DOI":"10.1007\/s00018-012-1122-2","article-title":"EMT-activating transcription factors in cancer: beyond EMT and tumor invasiveness","volume":"69","author":"Sanchez-Tillo","year":"2012","journal-title":"Cell Mol. Life Sci."},{"key":"10.1016\/j.biopha.2024.116259_bib34","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2005189","article-title":"Signaling mechanisms of the epithelial-mesenchymal transition","volume":"7","author":"Gonzalez","year":"2014","journal-title":"Sci. Signal"},{"key":"10.1016\/j.biopha.2024.116259_bib35","article-title":"Apolipoprotein C-II induces EMT to promote gastric cancer peritoneal metastasis via PI3K\/AKT\/mTOR pathway","volume":"11","author":"Wang","year":"2021","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.biopha.2024.116259_bib36","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41589-019-0411-6","article-title":"Structural basis of indisulam-mediated RBM39 recruitment to DCAF15 E3 ligase complex","volume":"16","author":"Bussiere","year":"2020","journal-title":"Nat. Chem. Biol."},{"key":"10.1016\/j.biopha.2024.116259_bib37","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/j.celrep.2019.09.079","article-title":"Aryl sulfonamides degrade RBM39 and RBM23 by recruitment to CRL4-DCAF15","volume":"29","author":"Ting","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.biopha.2024.116259_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2021.188549","article-title":"HER2-targeted therapies in gastric cancer","volume":"1876","author":"Zhu","year":"2021","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"key":"10.1016\/j.biopha.2024.116259_bib39","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13046-016-0487-8","article-title":"Resveratrol reverses doxorubicin resistance by inhibiting epithelial-mesenchymal transition (EMT) through modulating PTEN\/Akt signaling pathway in gastric cancer","volume":"36","author":"Xu","year":"2017","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.biopha.2024.116259_bib40","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1006\/mcne.1999.0750","article-title":"Evidence for and against a pivotal role of PI 3-kinase in a neuronal cell survival pathway","volume":"13","author":"Williams","year":"1999","journal-title":"Mol. Cell Neurosci."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224001409?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332224001409?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T13:51:11Z","timestamp":1760104271000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332224001409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":40,"alternative-id":["S0753332224001409"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116259","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Subtle structural alteration in indisulam switches the molecular mechanisms for the inhibitory effect on the migration of gastric cancer cells","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2024.116259","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"116259"}}